Evaluation of coagulation tests before newborn circumcision: is it necessary?

Area of Science:

• Pediatric Surgery
• Hematology
• Neonatal Care

Background:

• Routine preoperative coagulation screening is common practice before newborn circumcision in many countries.
• The clinical utility of prothrombin time (PT) and activated partial thromboplastin time (aPTT) in predicting bleeding risk after circumcision is not well-established.
• Healthy term newborns without a family history of bleeding disorders are generally considered low risk for surgical complications.

Purpose of the Study:

• To evaluate the correlation between prolonged preoperative PT and aPTT and excessive bleeding following circumcision in healthy term newborns.
• To determine if routine coagulation parameter evaluation is necessary for elective newborn circumcision in the absence of risk factors.

Main Methods:

• Retrospective review of medical records of 450 healthy, full-term newborns circumcised within the first week of life.
• Data collected included family history of coagulopathy, signs of bleeding, preoperative PT and aPTT levels, and post-circumcision bleeding amount.
• Patients were monitored for any late-diagnosed bleeding disorders.

Main Results:

• None of the 450 newborns had a family history or clinical signs of bleeding disorders.
• A significant proportion had prolonged PT (59%) and/or aPTT (35%) results.
• No correlation was found between prolonged PT/aPTT and excessive bleeding after circumcision.

Conclusions:

• Preoperative evaluation of PT and aPTT is not necessary for elective newborn circumcision in healthy infants without clinical bleeding or a family history of bleeding disorders.
• Current screening practices may be driven by habit or defensive medicine rather than clinical evidence.
• Focusing on clinical assessment and family history is sufficient for risk stratification in this population.